Japan’s drug pricing panel held its final round of industry hearings on December 10 as it heads toward the FY2026…
HOME > BUSINESS
BUSINESS
- Ethical Drug Sales Up 6.1% in March: Crecon Report
May 30, 2016
- Application Filing Expected in FY2018 for Cancer Peptide Vaccine Originating from Kurume Univ.
May 30, 2016
- Kyorin to Exclusively Market MSD’s Desloratadine in Japan
May 27, 2016
- Astellas Grants Thunderbolt Pharma Rights for BAFF/APRIL Dual Antagonist Program
May 26, 2016
- Eisai Rolls Out AMPA Receptor Antagonist Fycompa
May 26, 2016
- AZ Launches Tagrisso for Treatment of NSCLC
May 26, 2016
- Shionogi’s Naldemedine Delivers Positive Results in Global PIII
May 25, 2016
- Hyperparathyroidism Drug Etelcalcetide Meets Primary Endpoint in Japan PIII: Ono
May 25, 2016
- Toyama Chemical Files Ozex for Mycoplasma Pneumoniae at Request of Academic Societies
May 25, 2016
- Bardoxolone Methyl Improves Renal Function in Japan PII: Kyowa Kirin
May 24, 2016
- PCSK9 Inhibitor Alirocumab Lowers LDL-C in Japanese Diabetes Patients: PIII Sub-Analysis
May 24, 2016
- Japan’s Top 3 Drug Makers Join Forces on Biomarker Research
May 24, 2016
- Repatha Shows Safety, Efficacy in Japanese Patients Regardless of Glycemic Status: Subanalysis Data
May 24, 2016
- Ozawa to Step Down as J-TEC CEO, Fujifilm’s Hiruma to Take Over
May 23, 2016
- Jiangsu Hengrui Medicine Eyes Launch of 2-3 Generics in Japan Every Year: CEO
May 23, 2016
- Generic Makers Enjoy Revenue Rises as Govt Tailwinds Continue: Jiho Tally
May 23, 2016
- Chugai, Osaka Univ. Clinch 10 Billion Yen Immunology Pact
May 20, 2016
- Ono Ties Up with Univ. of Tokyo Venture for Antibody Drug
May 19, 2016
- Suzuken Outstrips Medipal in Drug Wholesaling Biz on Hep C Boom: Jiho Tally
May 19, 2016
- Takecab Most Heavily Pitched Drug for 3 Consecutive Months: Anterio
May 18, 2016
ページ
Japan has presented its latest draft policy direction for its FY2026 drug pricing reform. While the package includes a string…
Let’s be real: even with the best intentions, AI systems can reflect our own unconscious biases. As Daniel Kahneman and Amos Tversky famously demonstrated in their groundbreaking work on Prospect Theory, humans are prone to cognitive biases that influence our…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…